226 related articles for article (PubMed ID: 23300597)
1. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
[TBL] [Abstract][Full Text] [Related]
2. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
[TBL] [Abstract][Full Text] [Related]
4. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer.
Sun T; Yang M; Chen S; Balk S; Pomerantz M; Hsieh CL; Brown M; Lee GM; Kantoff PW
Prostate; 2012 Jul; 72(10):1093-103. PubMed ID: 22127852
[TBL] [Abstract][Full Text] [Related]
5. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.
Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N
Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396
[TBL] [Abstract][Full Text] [Related]
6. MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2.
Zheng C; Yinghao S; Li J
Med Oncol; 2012 Jun; 29(2):815-22. PubMed ID: 21487968
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
[TBL] [Abstract][Full Text] [Related]
8. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma.
Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H
J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580
[TBL] [Abstract][Full Text] [Related]
9. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ
BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120
[TBL] [Abstract][Full Text] [Related]
10. miR-200b inhibits prostate cancer EMT, growth and metastasis.
Williams LV; Veliceasa D; Vinokour E; Volpert OV
PLoS One; 2013; 8(12):e83991. PubMed ID: 24391862
[TBL] [Abstract][Full Text] [Related]
11. MiR-345 suppresses proliferation, migration and invasion by targeting Smad1 in human prostate cancer.
Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ
J Cancer Res Clin Oncol; 2016 Jan; 142(1):213-24. PubMed ID: 26227059
[TBL] [Abstract][Full Text] [Related]
12. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
[TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.
Ma S; Chan YP; Kwan PS; Lee TK; Yan M; Tang KH; Ling MT; Vielkind JR; Guan XY; Chan KW
Cancer Res; 2011 Jan; 71(2):583-92. PubMed ID: 21224345
[TBL] [Abstract][Full Text] [Related]
15. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
17. The MicroRNA-23b/27b/24 Cluster Facilitates Colon Cancer Cell Migration by Targeting FOXP2.
Nishida K; Kuwano Y; Rokutan K
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936744
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of aberrantly expressed microRNAs in prostate cancer.
Goto Y; Kurozumi A; Enokida H; Ichikawa T; Seki N
Int J Urol; 2015 Mar; 22(3):242-52. PubMed ID: 25599923
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells.
Wang L; Alcon A; Yuan H; Ho J; Li QJ; Martins-Green M
Integr Biol (Camb); 2011 Jul; 3(7):742-54. PubMed ID: 21594291
[TBL] [Abstract][Full Text] [Related]
20. The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin.
Ell B; Qiu Q; Wei Y; Mercatali L; Ibrahim T; Amadori D; Kang Y
J Biol Chem; 2014 Aug; 289(32):21888-95. PubMed ID: 24966325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]